Table 1.
Baseline characteristics of patients.
| Variable | Placebo (n = 28) | Nano-curcumin (n = 27) | P value |
|---|---|---|---|
| Age (years) | 53.85 ± 10.48† | 50.48 ± 12.07† | 0.27 |
| Gender (Male, %) | 12 (42.9%) | 16 (59.3%) | 0.22 |
| Height (cm) | 164.62 ± 11.65† | 169.12 ± 10.01† | 0.13 |
| Diabetes (%) | 11 (39.3%) | 11 (40.7%) | 0.91 |
| Physical activity (MET-hr/day) | 29.66 ± 2.93† | 31.17 ± 3.25† | 0.07 |
| Creatinine (mg/dl) | 0.85 ± 0.14† | 0.89 ± 0.20† | 0.42 |
Qualitative data were analyzed using the Pearson Chi-Square test, while quantitative data were analyzed using the Independent Sample t-test.
†Mean ± Standard Deviation.